TABLE 1.
Baseline characteristics of the patients with large vessel occlusion with and without COVID‐19
| Variables | Non‐COVID‐19 | COVID‐19 | Total | p |
| (N = 395) | (N = 302) | (N = 697) | ||
| Mean (SD) age, years | 71.0 (15.8) | 61.1 (15.7) | 67.1 (16.5) | <0.001* |
| Gender: female, n (%) | 318 (80.5) | 124 (41.1) | 442 (63.4) | <0.001* |
| Pre‐admission mRS score 0–2, n (%) | 380 (96.2) | 198 (65.6) | 578 (82.9) | <0.001* |
| Mean (SD) NIHSS score at admission | 14.3 (7.5) | 17.2 (8.5) | 15.4 (8.0) | <0.001* |
| Hypertension, n (%) | 271 (68.8) | 174 (57.6) | 445 (63.8) | 0.104 |
| Chronic heart disease, n (%) | 136 (34.4) | 57 (18.9) | 193 (27.7) | <0.001* |
| Chronic lung disease, n (%) | 76 (19.2) | 60 (19.9) | 136 (19.5) | 0.575 |
| Chronic kidney disease, n (%) | 43 (10.9) | 28 (9.3) | 71 (10.2) | 0.791 |
| Chronic liver disease, n (%) | 10 (2.5) | 18 (6.0) | 28 (4.0) | 0.022* |
| Diabetes mellitus (type 2), n (%) | 88 (22.3) | 89 (29.5) | 177 (25.4) | 0.014* |
| Atrial fibrillation, n (%) | 151 (38.2) | 64 (21.2) | 215 (30.8) | <0.001* |
| New onset atrial fibrillation, n (%) | 0 (0.0) | 21 (7.0) | 21 (3.0) | 0.238 |
Note: Missing data count per variable: age, n = 53; gender n = 17; pre‐admission mRS score, n = 70; NIHSS at admission, n = 72; hypertension, n = 40; chronic heart disease, n = 24; chronic lung disease, n = 22; chronic kidney disease, n = 24; chronic liver disease, n = 22; diabetes mellitus (type 2), n = 31; atrial fibrillation, n = 31; new onset atrial fibrillation, n = 417.
Abbreviations: mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SD, standard deviation.
*
Statistically significant.